Exploring the neurobiological mechanisms of ketamine, psychedelics, and other rapid antidepressants
Explore the archives below.
July 18, 2022
Amelia Christensen (Kepecs lab, WashU Neuroscience)
“Interactions between psychedelic agonism of 5ht2a receptors and dopamine dependent reinforcement learning”
August 15, 2022
NOTE 3:00p start time
Rick Reneau (Braver lab, WashU Psychological & Brain Sciences)
“Imaging the effect of ketamine on synaptic density (SV2A) in the living brain” Molecular Psychiatry (2022)
September 19, 2022
Oliver Krentzman (Kepecs lab, WashU Neuroscience)
“Oxytocin-dependent reopening of a social reward learning critical period with MDMA” (Nature 2019)
October 17, 2022
Peter Lambert (Mennerick lab, WashU Psychiatry)
“Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2” (Neuron 2022)
November 21, 2022
Joshua Siegel (Nicol lab, WashU Psychiatry)
Jonah Padawer-Curry (Bauer lab, WashU Radiology)
WiP: “Neural and neurovascular effects of 5-HT2A receptor modulation (psychedelic, non-psychedelic agonism, and antagonism)”
